25 assets in Diabetic Neuropathy

Therapeutic assets addressing Diabetic Neuropathy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Duloxetine Diabetic Neuropathy	Aga Khan University	P4	A (81)
Mirogabalin Diabetic Neuropathy	Bangladesh Medical University	P4	BBB (79)
Pregabalin Diabetic Neuropathy	Shandong Suncadia Medicine Co., Ltd.	P4	BBB (76)
bay2395840 Diabetic Neuropathy	Bayer	P2	BB (64)
Adezunap Diabetic Neuropathy	Apurano Pharmaceuticals GmbH	P3	B (60)
Crisugabalin Diabetic Neuropathy	Haisco Pharmaceutical Group Co., Ltd.	P2/3	B (60)
Pilavapadin Diabetic Neuropathy	Lexicon Pharmaceuticals	P2	B (60)
Fepixnebart Diabetic Neuropathy	Eli Lilly and Company	P2	B (57)
ly3556050 Diabetic Neuropathy	Eli Lilly and Company	P2	B (57)
ly3857210 Diabetic Neuropathy	Eli Lilly and Company	P2	B (57)
(S)-2-(3-Methyl-1-((3-Methyl-1,2,4-Oxadiazol-5-Yl)Methyl)-2,6-Dioxo-1,2,3,6-Tetrahydro-7H-Purin-7-Yl)-N-(6-(2-(Trifluoromethyl)Pyrimidin-5-Yl)Pyridin-2-Yl)Propanamide Diabetic Neuropathy	Eli Lilly and Company	P2	B (57)
Suzetrigine Diabetic Neuropathy	Vertex Pharmaceuticals Incorporated	P3	B (57)
Incobotulinumtoxin-A Diabetic Neuropathy	Rigshospitalet, Denmark	P2	CCC (53)
Jmkx000623 Diabetic Neuropathy	Jemincare	P2	CCC (53)
ly4065967 Diabetic Neuropathy	Eli Lilly and Company	P2	CCC (53)
Rta 901 Diabetic Neuropathy	Reata, a wholly owned subsidiary of Biogen	P2	CCC (53)
VX-993 Diabetic Neuropathy	Vertex Pharmaceuticals Incorporated	P2	CCC (53)
Palmitic Monoethanolamide Diabetic Neuropathy	Pure Green Pharmaceuticals Inc.	P1/2	CC (45)
Ajh-2947 Diabetic Neuropathy	JMackem Co., Ltd	P1	CC (43)
Hrs-2129 Diabetic Neuropathy	Shandong Suncadia Medicine Co., Ltd.	P1	CC (41)
yj001 Diabetic Neuropathy	Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.	P1	CC (41)
Capsaicin Palmitate Diabetic Neuropathy	Carilion Clinic	Early P1	C (39)
Trans-Resveratrol Diabetic Neuropathy	University of Sulaimani	N/A	D (30)
Urea Diabetic Neuropathy	Universidad Complutense de Madrid	N/A	D (30)
hl-1186 Diabetic Neuropathy	Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.	P2	NR ()